Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220772) titled 'A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults' on Oct. 22.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Regeneron Pharmaceuticals
Condition:
Monogenic Obesity
Intervention:
Drug: Mibavademab
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: December 19, 2025
Target Sample Size: 4
To know more, visit https://clinicaltrials.gov/study/NCT07220772
Published by HT Digital Conte...